In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery. [PDF]
Int J Nanomedicine, 2021 Xu H +5 more
europepmc +1 more source
Compatibility Studies of Different Crystal Forms of Imatinib Mesylate with Pharmaceutical Excipients. [PDF]
ACS OmegaMou Y +6 more
europepmc +1 more source
Imatinib Mesylate for the Treatment of Canine Mast Cell Tumors: Assessment of the Response and Adverse Events in Comparison with the Conventional Therapy with Vinblastine and Prednisone. [PDF]
Cells, 2022 Macedo TR +9 more
europepmc +1 more source
Toxicity assessment of imatinib mesylate and a related impurity: in vitro and in vivo approaches. [PDF]
Toxicol Res (Camb)Rocha CFRDS +9 more
europepmc +1 more source
Imatinib Mesylate-Induced Acquired Dermal Melanocytosis and Acquired Bilateral Nevus of Ota-Like Macules. [PDF]
Ann Dermatol, 2021 Jang JW +6 more
europepmc +1 more source
Erythema following imatinib mesylate [PDF]
British Journal of Haematology, 2003 Duncan, E, Raj, K, Mufti, G
openaire +2 more sources
Molecular ablation of transforming growth factor beta signaling pathways by tyrosine kinase inhibition: the coming of a promising new era in the treatment of tissue fibrosis. [PDF]
, 2008 Jimenez, Sergio A., Rosenbloom, Joel
core +1 more source
Claudin-1 Contributes to Gastrointestinal Stromal Tumors (GIST) Resistance to Imatinib Mesylate (IM) via Regulation of FGFR-Signaling. [PDF]
Int J Mol SciBoichuk S +13 more
europepmc +1 more source
Imatinib mesylate promotes melanogenesis through the modulation of p38 and MITF in murine cells. [PDF]
Toxicol ResTalapphet N, Kim MM.
europepmc +1 more source